Latest Bladder Cancer News
In a small study, 56% of NMIBC patients who received the dual regimen after failing treatment with BCG alone were tumor free.
Cisplatin-based chemotherapy after radical cystectomy for high-risk bladder cancer decreased the risk of death from the malignancy by 29%.
ABO blood may be useful in risk-stratification of patients who may benefit from more aggressive treatment and/or altered surveillance regimens.
Population-based Australian data from 2001-2009 show better 5-year disease-specific and overall survival rates compared with older studies.
Computed tomography (CT) scans prior to radical cystectomy for invasive bladder cancer may be useful.
The malignancy is 36% less likely to develop, after adjusting for age and smoking, data show.
IsoFlux test showed 10 or more circulating tumor cells in four of nine samples, versus 0 with CellSearch.
New data suggest a prognosis role for the neutrophil to lymphocyte ratio.
Older adults react differently to treatment, oncology group notes.
Almost 1 in 3 not told cancer treatment might affect future fertility.
No improvement in quality of life, even for patients with good baseline performance status.
But research reveals association with pancreatic and prostate cancer.
Bladder cancer patients with and without a history of pelvic irradiation have similar recurrence-free and cancer-specific survival rates.
Even 70% of smokers support the concept of raising the legal smoking age.
Preoperative weight loss greater than 10% and operative time more than 6 hours also increased the risk.
Bladder Cancer Videos
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)